 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
At AGBT, FDA Official Says Agency Will Regulate NGS-based Tests, Stressing 'Nothing is Finalized'
February 27, 2013
At AGBT, FDA Official Says Agency Will Regulate NGS-based Tests, Stressing 'Nothing is Finalized'
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- FDA Official Discusses Issues with Regulating NGS Dx Tests
June 20, 2012 / Clinical Sequencing News - GenomeWeb Feature: Will the Future of Genomics be Consumer Driven?
March 4, 2013 / GenomeWeb Daily News - Atossa Warned by FDA Over its MASCT Platform
February 25, 2013 / GenomeWeb Daily News - FDA Clinical PGx Guidance Pushes Early Consideration of Genomic Data in Drug Research
January 30, 2013 / Pharmacogenomics Reporter - Illumina Growing Clinical and Dx Business with Submission of MiSeqDx, Two CF Assays to FDA
January 9, 2013 / Clinical Sequencing News